BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home » Newsletters » BioWorld Science

BioWorld Science

July 8, 2020

View Archived Issues

Noncoding mutations contribute to heart disease

Read More

Good vs. evil in the synovial joint

Read More

Topline data presented from global phase II trial of SEP-4199 in bipolar I depression

Read More

Discovery of novel HDAC6 selective inhibitors with potent preclinical activity

Read More

ImmunoGen presents next-generation FR-alpha-targeting ADC, IMGN-151

Read More

Dana-Farber Cancer Institute presents new MAPK9 inhibitors

Read More

Theravance Biopharma patents TGFR-1 inhibitors

Read More

Prelude Therapeutics discloses Mcl-1 inhibitors

Read More

RemeGen describes new angiogenesis inhibitors

Read More

ImmuneOnco Biopharmaceuticals divulges anti-PD-L1 and anti-VEGF compounds

Read More

Enrollment completed in pivotal DERBY and OAKS studies of pegcetacoplan

Read More

Novel innovative COVID-19 drug testing platform launched in the U.K.

Read More

Cabaletta Bio and Artisan Bio collaborate to develop next-generation CAAR T-cell therapies

Read More

Engineered interleukin-18 ignores tumors' defenses

Read More

Potent, orally available AXL inhibitor DW-17401 reduces xenograft tumor growth

Read More

Anti-CCR8 MAb BMS-986340 shows promise as cancer immunotherapeutic

Read More

Allogeneic anti-PTK7 CAR-T cells may allow safe access to the anticancer target

Read More

New phase I trial evaluates Curis' IRAK-4 kinase inhibitor CA-4948 in AML and MDS

Read More

Pivotal study of F-627 for chemotherapy-induced neutropenia meets primary and secondary endpoints

Read More

Anti-HER3 antibody shows efficacy in vivo against NRG1 fusion-bearing tumors

Read More

Inqovi approved in U.S. and Canada for MDS

Read More

InMed begins second phase I trial of INM-755 for epidermolysis bullosa

Read More

GSK and Medicago collaborate on adjuvanted COVID-19 candidate vaccine

Read More

STK-001 studied for Dravet syndrome in new phase I/II study

Read More

Corvus begins phase I study of CPI-006 in COVID-19

Read More

Hepion reports promising preclinical data with CRV-431 supporting potential for COVID-19

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 4, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 4, 2025.
  • Green molecules

    UK Biobank delivers largest metabolomics dataset of 500K profiles

    BioWorld Science
    It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
  • 3D rendering of prion structure

    Epigenetic technology could eliminate misfolded prion proteins

    BioWorld Science
    The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
  • Mesothelin is biomarker, potential target in arthritic bone damage

    BioWorld Science
    In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing